English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Aim  Less invasive surfactant administration ( LISA ) has been shown to decrease the risk of death and bronchopulmonary dysplasia in preterm neonates. The  LISA cath is the first catheter to be specifically developed for  LISA , and we compared the clinical impressions of neonatologists using the  LISA cath and the commonly used Angiocath in a simulated setting.    Methods  This was a multinational, multicentre study, conducted in October 2016, which involved 39 neonatologists who were recruited by employees of the sponsor from large, well‐recognised neonatal intensive care units across Europe.  LISA  was not the standard of care in these units in Austria, Belgium, Poland, Spain and the  United Kingdom  at the time of the study. After training, participants simulated  LISA  on a neonatal manikin, once with the  LISA cath and once with Angiocath, then answered a 10‐item questionnaire.    Results  The responses to nine of 10 questions showed that 67‐95% of the respondents preferred the  LISA cath to the Angiocath, with most of the remainder indicating no preference. The only exception was the luer connection question, with two‐thirds expressing no preference. The  LISA cath was considered potentially safer by 33 of 39 participants, with no votes for the Angiocath.    Conclusion  Overall, neonatologists preferred using the  LISA cath rather than the Angiocath on a neonatal manikin.

acta paediatrica

Five‐country manikin study found that neonatologists preferred using the  LISA cath rather than the Angiocath for less invasive surfactant administration